Deadly Biological Agent Control Act of 2001
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Nov 8, 2001)
Amends the AEDPA to direct the Secretary of HHS to: (1) annually review the existing list of select agents and, if necessary, revise the list; (2) prioritize countermeasures, including vaccines, therapies, medical devices, and diagnostic tests which must be developed, produced, or obtained in preparation for a bioterrorist attack or other significant disease emergency to treat, prevent, or identify infection by, or exposure to, listed biological agents and toxins (listed agents); and (3) provide for the establishment and enforcement of standards and procedures governing the possession and use of listed agents.
Requires the Secretary to establish a certification process for the possession and use of listed agents. Sets forth legitimate purposes. Requires any individual who handles listed agents to pass a criminal background check, including a determination of whether that individual is a restricted person, and to be registered with the Department of HHS for the specific research project that requires the use of biological agents or toxins.
Sets penalties for violations.
What just happenedNov 8, 2001
Read twice and referred to the Committee on the Judiciary.
Who’s behind it
- Nov 8, 2001IntroReferral
Read twice and referred to the Committee on the Judiciary.
Judiciary Committee - Nov 8, 2001IntroReferralB00100
Sponsor introductory remarks on measure. (CR S11615)
- Nov 8, 2001IntroReferral10000
Introduced in Senate